SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

CAPS Rating: 5 out of 5

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Recs

1
Player Avatar Nightshaded (21.99) Submitted: 5/13/2011 7:08:46 PM : Outperform Start Price: $4.30 SCLN Score: +36.54

This biotech, I mean volcano, is beginning to smoke. First I highly recommend doing YOUR OWN research, I can't express this enough. Do not base your decisions from what myself or some total stranger claims, which could be tainted with hidden motives and selfish pursuits. Being said, SCLN reminds me of an ex-girlfriend, an emotional roller coaster who rocked my world. With the new sales force and high projected sales, I see this babe reaching new heights. I also believe something is taking place behind closed curtains, which would explain the intense gain this week. Forget an American werewolf in London, here comes the American Biotech in China!!! Good luck to all! Rubi194@aol.com

Member Avatar Nightshaded (21.99) Submitted: 3/14/2012 7:45:27 PM
Recs: 0

SCLN made me proud today. Congrats longs.

Featured Broker Partners


Advertisement